Frederique Defrance
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.
Journal: Science translational medicine
Published: March 25, 2026
Association between HOMA2 based beta-cell function or insulin resistance and long-term outcomes in kidney transplant recipients with type 2 diabetes.
Journal: Scientific reports
Published: January 23, 2024
Real-life experience with DPP4 inhibitors for graft dysfunction after human islet allotransplantation.
Journal: Annales d'endocrinologie
Published: December 27, 2023
Primary Graft Function and 5 Year Insulin Independence After Pancreas and Islet Transplantation for Type 1 Diabetes: A Retrospective Parallel Cohort Study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: August 22, 2023
Cognitive Outcome After Islet Transplantation.
Journal: Transplantation direct
Published: October 10, 2022
The challenge of HLA donor specific antibodies in the management of pancreatic islet transplantation: an illustrative case-series.
Journal: Scientific reports
Published: April 28, 2022
Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review.
Journal: Clinical chemistry and laboratory medicine
Published: January 26, 2019
Impact of Procedure-Related Complications on Long-term Islet Transplantation Outcome.
Journal: Transplantation
Published: November 14, 2014
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation.
Journal: Orphanet journal of rare diseases
Published: July 30, 2014
Treating diabetes with islet transplantation: lessons from the past decade in Lille.
Journal: Diabetes & metabolism
Published: July 08, 2013
Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
Journal: The Journal of clinical endocrinology and metabolism
Published: September 22, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026